These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 26285106

  • 1. Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx).
    Krasuska-Sławińska E, Minko-Chojnowska I, Pawłowska J, Dembowska-Bagińska B, Pronicki M, Olczak-Kowalczyk D.
    Ann Transplant; 2015 Aug 18; 20():478-82. PubMed ID: 26285106
    [Abstract] [Full Text] [Related]

  • 2. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S, German PTLD Study Group, European PTLD Network.
    Lancet Oncol; 2012 Feb 18; 13(2):196-206. PubMed ID: 22173060
    [Abstract] [Full Text] [Related]

  • 3. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.
    Transplant Proc; 2011 Nov 18; 43(9):3299-301. PubMed ID: 22099782
    [Abstract] [Full Text] [Related]

  • 4. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep 18; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
    Kuriyama T, Kawano N, Yamashita K, Ueda A.
    J Clin Exp Hematop; 2014 Sep 18; 54(2):149-53. PubMed ID: 25318948
    [Abstract] [Full Text] [Related]

  • 6. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
    Transplant Proc; 2010 Jun 18; 42(5):1763-8. PubMed ID: 20620519
    [Abstract] [Full Text] [Related]

  • 7. Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.
    Sprangers B, Riella LV, Dierickx D.
    Am J Kidney Dis; 2021 Aug 18; 78(2):272-281. PubMed ID: 33774079
    [Abstract] [Full Text] [Related]

  • 8. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S.
    Transplantation; 2007 Apr 15; 83(7):912-8. PubMed ID: 17460562
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
    Mumtaz K, Faisal N, Marquez M, Healey A, Lilly LB, Renner EL.
    Can J Gastroenterol Hepatol; 2015 Apr 15; 29(8):417-22. PubMed ID: 26076399
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of intraocular post-transplant lymphoproliferative disorder with intravenous rituximab.
    Iu LP, Yeung JC, Loong F, Chiang AK.
    Pediatr Blood Cancer; 2015 Jan 15; 62(1):169-72. PubMed ID: 25174958
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant Lymphoproliferative Disorder in Recipient's Reconstructed Middle Hepatic Vein After Pediatric Living Donor Liver Transplant: A Case Report.
    Li H, Zhu Z, Wei L, Zeng Z, Qu W.
    Transplant Proc; 2021 May 15; 53(4):1308-1312. PubMed ID: 33358421
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
    Patel H, Vogl DT, Aqui N, Shaked A, Olthoff K, Markmann J, Reddy R, Stadtmauer EA, Schuster S, Tsai DE.
    Leuk Lymphoma; 2007 May 15; 48(5):885-91. PubMed ID: 17487731
    [Abstract] [Full Text] [Related]

  • 13. Long-term remission in an adult heart transplant recipient with advanced Burkitt's lymphoma post-transplant lymphoproliferative disorder after anthracycline-free chemotherapy: A case report and literature review.
    AbdelHameid D, Felice A, Cooper LB, Katugaha SB.
    Transpl Infect Dis; 2020 Aug 15; 22(4):e13265. PubMed ID: 32077552
    [Abstract] [Full Text] [Related]

  • 14. EBV and posttransplantation lymphoproliferative disease: what to do?
    Zimmermann H, Trappe RU.
    Hematology Am Soc Hematol Educ Program; 2013 Aug 15; 2013():95-102. PubMed ID: 24319169
    [Abstract] [Full Text] [Related]

  • 15. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov 15; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 16. Managing the challenge of PTLD in liver and bowel transplant recipients.
    Lauro A, Arpinati M, Pinna AD.
    Br J Haematol; 2015 Apr 15; 169(2):157-72. PubMed ID: 25377273
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorder after paediatric liver transplantation.
    Liu Y, Sun LY, Zhu ZJ, Wei L, Qu W, Wang L, Yuan LL, Zeng ZG.
    Int J Clin Pract; 2021 Apr 15; 75(4):e13843. PubMed ID: 33222369
    [Abstract] [Full Text] [Related]

  • 18. Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child.
    Hayashida M, Ogita K, Matsuura T, Takahashi Y, Nishimoto Y, Ohga S, Hara T, Soejima Y, Taketomi A, Maehara Y, Kohashi K, Tsuneyoshi M, Taguchi T.
    Pediatr Transplant; 2007 Sep 15; 11(6):671-5. PubMed ID: 17663692
    [Abstract] [Full Text] [Related]

  • 19. The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients.
    McCarthy M, Ramage J, McNair A, Gane E, Portmann B, Pagliuca A, Rela M, Heaton N, Mufti GJ, Williams R.
    J Hepatol; 1997 Dec 15; 27(6):1015-21. PubMed ID: 9453427
    [Abstract] [Full Text] [Related]

  • 20. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
    Liver Transpl; 2007 Jun 15; 13(6):904-12. PubMed ID: 17539010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.